Why this route

Authors are allowed to send you their own paper, and most are pleased to be asked. It is free, it is how researchers have always shared work, and it reaches the papers no index will give up. Reply rates on requests like these are good, and better when the person asking is clearly a real reader rather than a harvester.

Nothing has been sent. These are drafts. Tell me which to send, or say send all, and I will. Your name and address are on them, so you should be happy with the wording first.

Each is short on purpose. A specific, human, three-line request outperforms a long formal one.

The standard text

Subject: Request for a copy of your paper on [topic]

Dear Dr [Name],

I am writing about your paper, "[Title]" ([Journal], [Year]).

I am a medical technologist writing about testosterone in women, and I read the primary literature rather than summaries of it. Your paper is behind a paywall I cannot get past. If you are able to send a copy of the accepted manuscript, I would be grateful, and I will cite it properly.

Thank you for your work on this.

Annette Thompson annettethompson.com

The 18 drafts

No address found: 32

For these I could not find a corresponding-author address automatically. They are still reachable, the address is usually on the paper's abstract page or the author's university profile, it just needs a human eye.

• Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. (Psychosomatic Medicine 1985)
• The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society (Menopause 2005)
• Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy (Climacteric 2009)
• Vaginal Health: Insights, Views & Attitudes (VIVA), results from an international survey (Climacteric 2011)
• Efficacy and Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder: A Systematic Review and Meta-Analysis (The Journal of Sexual Medicine 2015)
• Management of Genitourinary Syndrome of Menopause (GSM) (Essentials of Menopause Management 2017)
• Genitourinary Syndrome of Menopause (GSM) and Vulvovaginal Atrophy (Advanced Health Assessment of Women 2018)
• Testosterone and Estrone Increase From the Age of 70 Years: Findings From the Sex Hormones in Older Women Study (The Journal of Clinical Endocrinology & Metabolism 2019)
• Pelvic floor muscle training: mechanisms of action for the improvement of genitourinary syndrome of menopause (Climacteric 2020)
• Vaginal oestrogen is a treatment on the rise, but is it safe? (BMJ 2024)
• Systemic testosterone for the treatment of female sexual interest and arousal disorder (FSIAD) in the postmenopause (Gynecological Endocrinology 2024)
• The genitourinary syndrome of menopause (Menopause 2025)
• The unmet needs of breast cancer survivors: is menopausal hormone therapy ever an option? (Menopause 2025)
• The primary care management of perimenopausal depression (Australian Journal of General Practice 2026)
• Fiber type-specific hypertrophy and increased capillarization in skeletal muscle following testosterone administration in young women (Journal of Applied Physiology 2020)
• Use of transdermal testosterone to treat menopausal symptoms in women with a history of breast cancer: a small, retrospective, open-label study (Menopause 2026)
• Subcutaneous Injection of Testosterone Is an Effective and Preferred Alternative to Intramuscular Injection: Demonstration in Female-to-Male Transgender Patients (The Journal of Clinical Endocrinology & Metabolism 2017)
• Synthesis and Actions of 5α-Reduced Metabolites of Testosterone in the Nervous System (Androgens: Clinical Research and Therapeutics 2021)
• Testosterone metabolism in brain cells and membranes (The Journal of Steroid Biochemistry and Molecular Biology 1991)
• Sex differences in the distribution of androgen receptors in the human hypothalamus (The Journal of Comparative Neurology 2000)
• Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations (Journal of Women's Health 2019)
• The role of menopausal hormone therapy in the management of osteoporosis (Climacteric 2015)
• Understanding weight gain at menopause (Climacteric 2012)
• Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis (The Journal of Clinical Endocrinology & Metabolism 2015)
• Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials (JAMA 2020)
• The 2022 hormone therapy position statement of The North American Menopause Society (Menopause 2022)
• Elimination of the Black Box Warning on Menopausal Hormone Therapy (Obstetrics & Gynecology 2026)
• The Women's Health Initiative trials of menopausal hormone therapy: lessons learned (Menopause 2020)
• Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality (JAMA 2017)
• Cardiovascular outcomes of menopause hormone therapy initiated in women aged ≥60 years or ≥10 years post-menopause: A systematic review of the literature (Post Reproductive Health 2025)
• The Timing Hypothesis: Hormone Therapy for Treating Symptomatic Women During Menopause and Its Relationship to Cardiovascular Disease (Journal of Women's Health 2019)
• Effects of Sleep Fragmentation and Estradiol Decline on Cortisol in a Human Experimental Model of Menopause (The Journal of Clinical Endocrinology & Metabolism 2023)